Literature DB >> 11920290

Influence of CD4 cell counts on the genetic heterogeneity of hepatitis C virus in patients coinfected with human immunodeficiency virus.

Anne Marie Roque-Afonso1, Mathieu Robain, Danielle Simoneau, Patricia Rodriguez-Mathieu, Michèle Gigou, Laurence Meyer, Elisabeth Dussaix.   

Abstract

To study the effects of reduced CD4 T cell activity on hepatitis C virus (HCV) genetic heterogeneity, HCV quasi-species complexity and diversification over time were analyzed for 56 human immunodeficiency virus-coinfected patients. Patients were selected retrospectively from the French Seroconverter Cohort (SEROCO) and the French Hemophilia Cohort (HEMOCO) for having stable CD4 cell counts for 3 years. HCV complexity was assessed by single-strand conformation polymorphism analysis of the envelope-coding region (HVR) and the core region at 2 time points 3 years apart. Increased HVR complexity was associated with higher CD4 cell count and HCV genotype 1 infection. Qualitative variation of HVR and core region was not related to CD4 cell count and depended on the initial complexity. Complexity of both regions remained unchanged over 3 years. Among these HCV-HIV-coinfected patients with stable CD4 cell counts, viral genotype and CD4 cell count may have influenced HVR complexity before their inclusion in the study but were not involved in HVR diversification during the 3-year follow-up period.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11920290     DOI: 10.1086/339297

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Seronegative hepatitis C virus infection in a child infected via mother-to-child transmission.

Authors:  Ariane Larouche; Geneviève Gaëtan; Nabil El-Bilali; Mathieu Quesnel-Vallières; Steven R Martin; Fernando Alvarez; Naglaa H Shoukry; Hugo Soudeyns
Journal:  J Clin Microbiol       Date:  2012-04-25       Impact factor: 5.948

2.  Influence of increased CD4 cell counts on the genetic variability of hepatitis C virus in patients co-infected with human immunodeficiency virus I.

Authors:  Xue-Ping Wang; Leslie Goodwin; Pamela Kahn; Craig Gawel; Cheston B Cunha; Benjamin Laser; Benjamin Sahn; Mark H Kaplan
Journal:  J Biomol Tech       Date:  2006-07

3.  Hepatitis C virus transmission bottlenecks analyzed by deep sequencing.

Authors:  Gary P Wang; Scott A Sherrill-Mix; Kyong-Mi Chang; Chris Quince; Frederic D Bushman
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

4.  Plasma and liver hepatitis C virus variability in patients coinfected with human immunodeficiency virus.

Authors:  Anne-Christine Jouvencel; Didier Neau; Muriel Faure; Martine Neau; Christophe Martinaud; Elisabeth Legrand; Pascale Trimoulet; Isabelle Garrigue; Brigitte Le Bail; Paulette Bioulac-Sage; Michel Dupon; Jean-Marie Ragnaud; Herve Fleury; Marie-Edith Lafon
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

5.  Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection.

Authors:  Silvana Gaudieri; Andri Rauch; Lawrence P Park; Elizabeth Freitas; Susan Herrmann; Gary Jeffrey; Wendy Cheng; Katja Pfafferott; Kiloshni Naidoo; Russell Chapman; Manuel Battegay; Rainer Weber; Amalio Telenti; Hansjakob Furrer; Ian James; Michaela Lucas; Simon A Mallal
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

6.  Compartmentalization of hepatitis C virus (HCV) during HCV/HIV coinfection.

Authors:  Jason T Blackard; Yoichi Hiasa; Laura Smeaton; Denise J Jamieson; Irma Rodriguez; Kenneth H Mayer; Raymond T Chung
Journal:  J Infect Dis       Date:  2007-05-02       Impact factor: 5.226

7.  Genetic divergence of hepatitis C virus: the role of HIV-related immunosuppression.

Authors:  Dale M Netski; Qing Mao; Stuart C Ray; Robert S Klein
Journal:  J Acquir Immune Defic Syndr       Date:  2008-10-01       Impact factor: 3.731

8.  Hepatitis C virus quasispecies in HIV-infected women: role of injecting drug use and highly active antiretroviral therapy (HAART).

Authors:  Tomasz Laskus; Jeffrey Wilkinson; Roksana Karim; Wendy Mack; Marek Radkowski; Marina deGiacomo; Jonathan Nasseri; Zhi Chen; Jiaao Xu; Andrea Kovacs
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

9.  Differing patterns of liver disease progression and hepatitis C virus (HCV) quasispecies evolution in children vertically coinfected with HCV and human immunodeficiency virus type 1.

Authors:  Sophie Canobio; Cynthia M Guilbert; Myriam Troesch; Johanne Samson; Mireille Lemay; Veronique Anne Pelletier; Anne-Claude Bernard-Bonnin; Rafal Kozielski; Normand Lapointe; Steven R Martin; Hugo Soudeyns
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

10.  Vertical transmission of hepatitis C virus: a tale of multiple outcomes.

Authors:  Alejandro Escobar-Gutiérrez; Hugo Soudeyns; Ariane Larouche; Juan Carlos Carpio-Pedroza; Armando Martinez-Guarneros; Carlos A Vazquez-Chacon; Salvador Fonseca-Coronado; Lilian H T Yamasaki; Karina Ruiz-Tovar; Mayra Cruz-Rivera
Journal:  Infect Genet Evol       Date:  2013-10-18       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.